TaiwanJ Pharmaceuticals Co (ROCO:6549) Beta: 0.0175 (As of Jul. 05, 2026)


ROCO:6549 TaiwanJ Pharmaceuticals Co Ltd ROCO:6549
46 GF Score
Price NT$7.13
GF Value NT$11.94
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is TaiwanJ Pharmaceuticals Co Beta?

TaiwanJ Pharmaceuticals Co ROCO:6549 -0.83% 46 Beta is 0.0175 as of Jul. 05, 2026. GuruFocus rates ROCO:6549 with a GF Score™ of 46/100 and a GF Value™ of NT$11.94 (Possible Value Trap). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-05), TaiwanJ Pharmaceuticals Co's Beta is 0.0175.


TaiwanJ Pharmaceuticals Co  (ROCO:6549) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


TaiwanJ Pharmaceuticals Co Beta Related Terms


TaiwanJ Pharmaceuticals Co Beta Historical Data

* Premium members only.

The historical data trend for TaiwanJ Pharmaceuticals Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TaiwanJ Pharmaceuticals Co Beta Chart

TaiwanJ Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.98 0.72 0.18 0.11 0.00

TaiwanJ Pharmaceuticals Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.09 0.11 0.00 0.00

ROCO:6549 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, TaiwanJ Pharmaceuticals Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TaiwanJ Pharmaceuticals Co Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiwanJ Pharmaceuticals Co's Beta distribution charts can be found below:

* The bar in red indicates where TaiwanJ Pharmaceuticals Co's Beta falls into.


ROCO:6549
46GF Score
TaiwanJ Pharmaceuticals Co Ltd ROCO:6549
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TaiwanJ Pharmaceuticals Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.0175 mean?
TaiwanJ Pharmaceuticals Co (ROCO:6549) has a Beta of 0.0175 as of Jul. 05, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for TaiwanJ Pharmaceuticals Co and its competitors.
Is TaiwanJ Pharmaceuticals Co's Beta too high?
TaiwanJ Pharmaceuticals Co's current Beta is 0.0175. Overall, TaiwanJ Pharmaceuticals Co has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TaiwanJ Pharmaceuticals Co's Beta compare to VRTX and REGN?
TaiwanJ Pharmaceuticals Co's Beta of 0.0175 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for TaiwanJ Pharmaceuticals Co and its competitors. TaiwanJ Pharmaceuticals Co's current Beta is 0.0175. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiwanJ Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, TaiwanJ Pharmaceuticals Co (ROCO:6549) is currently considered Possible Value Trap. The stock's GF Value™ is NT$11.94, compared to a current price of NT$7.13 — trading 40.3% below its estimated fair value. The current Beta is 0.0175. TaiwanJ Pharmaceuticals Co's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For TaiwanJ Pharmaceuticals Co (ROCO:6549), the current Beta is 0.0175 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TaiwanJ Pharmaceuticals Co (ROCO:6549) Overvalued in 2026?

Based on GuruFocus' analysis, TaiwanJ Pharmaceuticals Co stock appears to be undervalued. The current stock price of NT$7.13 is trading 40.3% below its estimated GF Value™ of NT$11.94. GuruFocus considers TaiwanJ Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for ROCO:6549:

  • Beta: 0.0175
  • GF Value™: NT$11.94 vs. price of NT$7.13 (40.3% below fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TaiwanJ Pharmaceuticals Co Business Description

Address No. 6-1, Shengyi Road, 3F-4, Section 2, Hsinchu County, Zhubei, TWN, 30261
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.
46GF Score

Get the complete analysis for ROCO:6549

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$7.13
Price
NT$11.94
GF Value